Stockreport

Gemphire Provides Update On Development of Gemcabene

GEMPHIRE THERAPEUTICS INC COMMON  (GEMP) 
Last gemphire therapeutics inc common earnings: 5/9 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.gemphire.com
PDF FDA requests the Company provide additional data regarding the partial clinical hold Company continues Phase 2 development of gemcabene for NAFLD/NASH Company amends l [Read more]